Clinical trial
A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
NCT00231595 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00231595 |
|---|---|
| Title | A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of Topiramate in the Prophylaxis of Migraine |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine, Common Migraine, Classic Migraine, Headache |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 768 |
| Start date | Mar 1, 2001 |
| Completion | Nov 1, 2002 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 19, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: